Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 12/20 | 0.54 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.43 |
| ▸ | PTPRC | P08575 | 3/20 | 0.43 |
| ▸ | PTPRB | P23467 | 2/20 | 0.43 |
| ▸ | PTPRE | P23469 | 2/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.43 |
| ▸ | PTPRA | P18433 | 2/20 | 0.41 |
| ▸ | TNF | P01375 | 3/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | CNR2 | P34972 | 3/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13026595 | 0.93 | PTPN1 (0.52) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL17189416 | 0.91 | PTPN1 (0.53) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL8292908 | 0.85 | PTPN1 (0.60) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL14704057 | 0.83 | PTPN1 (0.42) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL8293361 | 0.77 | PTPN1 (0.69) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL6314541 | 0.72 | PTPN1 (1.00) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL5837972 | 0.63 | PTPN1 (1.00) | PTPN1PTPN2PTPRCPTPRBPTPRE | |
| SCHEMBL26271467 | 0.61 | EPHX2 (0.39) | KDM4EPOLBHSD17B10 | |
| SCHEMBL30921001 | 0.61 | ALDH1A1 (0.47) | KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL24397610 | 0.60 | ENO1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070203058-A1 | Novel Glp-1 Derivatives | NOVO NORDISK A/S (DK) | 2007-08-30 | — | — | US | disclosed |
| US-20070203058-A1 | Novel Glp-1 Derivatives | NOVO NORDISK A/S (DK) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203058-A1 | Novel Glp-1 Derivatives | GLP1R, GIPR, NPY4R | PTPN1 258/4885PTPN2 435/4885PTPRC 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.